Cargando…
The importance of greater speed in drug development for advanced malignancies
It takes on average 6–12 years to develop new anticancer drugs from discovery to approval. Effective new agents prolong survival. To demonstrate the importance of rapid drug approval, we calculated life‐years potentially saved if selected agents were approved more rapidly. As illustrative examples,...
Autores principales: | Stewart, David J., Stewart, Andrew A., Wheatley‐Price, Paul, Batist, Gerald, Kantarjian, Hagop M., Schiller, Joan, Clemons, Mark, Bradford, John‐Peter, Gillespie, Laurel, Kurzrock, Razelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943431/ https://www.ncbi.nlm.nih.gov/pubmed/29601671 http://dx.doi.org/10.1002/cam4.1454 |
Ejemplares similares
-
The need for speed in advanced non‐small cell lung cancer: A population kinetics assessment
por: Stewart, David J., et al.
Publicado: (2021) -
Dosing targeted and cytotoxic two‐drug combinations: Lessons learned from analysis of 24,326 patients reported 2010 through 2013
por: Nikanjam, Mina, et al.
Publicado: (2016) -
Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes
por: Kurzrock, Razelle, et al.
Publicado: (2015) -
Treatment Access, Health Economics, and the Wave of a Magic Wand
por: Stewart, David J., et al.
Publicado: (2022) -
Click chemistry, 3D-printing, and omics: the future of drug development
por: Kurzrock, Razelle, et al.
Publicado: (2015)